Scientific Publications Search Search Author Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Begay-Müller, Valerie Dr. (1) Birchmeier-Kohler, Carmen Prof. Dr. (1) Chekulaeva, Marina Dr. (2) Daniel, Peter Prof. Dr. (1) Daumke, Oliver Prof. Dr. (1) Franke, Vedran Dr. (1) Gotthardt, Michael Prof. Dr. (1) Haucke, Volker Professor (1) Heuser, Arnd Dr. (1) Kempa, Stefan Dr. (1) Kirchner, Marieluise Dr. (1) Ku, Min-Chi Dr. (1) Landthaler, Markus Prof. Dr. (1) Leutz, Achim Prof. Dr. (1) Lewin, Gary Prof. Dr. (1) Mathas, Stephan Dr. (9) Müller, Thomas Dr. (1) Niendorf, Thoralf Prof. Dr. (1) Ohler, Uwe Prof. Dr. (2) Poulet, James Prof. Dr. (1) Radke, Michael Dr. (1) Rajewsky, Nikolaus Prof. Dr. (1) Rocks, Oliver Dr. (1) Scheidereit, Claus Prof. Dr. (1) Schmitt, Clemens Prof. Dr. (1) Selbach, Matthias Prof. Dr. (12) Specker, Edgar Dr. (1) von Kries, Jens Peter Dr. (1) Woehler, Andrew Dr. (1) Wollert-Wulf, Brigitte (2) Zauber, Henrik Dr. (1) (-) Akalin, Altuna Dr. (1) (-) Janz, Martin Dr. (9) (-) Lusatis, Simone (1) 1999 (1) 2000 (1) 2002 (1) 2003 (3) 2004 (2) (-) 2005 (2) (-) 2006 (4) 2007 (2) 2008 (2) 2009 (3) 2010 (1) 2011 (4) 2012 (2) 2013 (2) 2014 (2) 2015 (2) 2016 (1) (-) 2017 (4) 2018 (2) 2019 (2) 2020 (4) 2021 (4) 2022 (4) 2023 (6) 2024 (2) Bioinformatics and Omics Data Science (8) (-) Biology of Malignant Lymphomas (9) Computational Regulatory Genomics (3) Developmental Biology / Signal Transduction (1) Epigenetic Regulation and Chromatin Architecture (2) Genetics and Genomics of Cardiovascular Diseases (1) Non-coding RNAs and Mechanisms of Cytoplasmic Gene Regulation (1) (-) Proteome Dynamics (1) RNA Biology and Posttranscriptional Regulation (1) Systems Biology Imaging (1) Systems Biology of Gene Regulatory Elements (3) 10 Results: Active Filter: Akalin, Altuna Dr.Janz, Martin Dr.Lusatis, SimoneBiology of Malignant LymphomasProteome Dynamics200520062017 Sort: Result score Newest to oldest Oldest to newest January 01, 2005 / Blood Immunomodulatory derivative of thalidomide (IMiD CC-4047) induces a shift in lineage commitment by suppressing erythropoiesis and promoting myelopoiesis K.R. Koh M. Janz M.Y. Mapara B. Lemke D. Stirling B. Doerken M. Zenke S. Lentzsch April 01, 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel February 01, 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken May 15, 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas August 25, 2005 / Blood Elevated NF-kappaB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large cell, and other peripheral T-cell lymphomas S. Mathas K. Joehrens S. Joos A. Lietz F. Hummel M. Janz F. Jundt I. Anagnostopoulos K. Bommert P. Lichter H. Stein C. Scheidereit B. Doerken March 15, 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou September 19, 2017 / Nat Commun RNA localization is a key determinant of neurite-enriched proteome A. Zappulo D. van den Bruck C. Ciolli Mattioli V. Franke K. Imami E. McShane M. Moreno-Estelles L. Calviello A. Filipchyk E. Peguero-Sanchez T. Müller A. Woehler C. Birchmeier E. Merino N. Rajewsky U. Ohler E.O. Mazzoni M. Selbach A. Akalin M. Chekulaeva December 13, 2017 / J Neurosci Graded elevation of c-Jun in Schwann cells in vivo: gene dosage determines effects on development, remyelination, tumorigenesis, and hypomyelination S.V. Fazal J.A. Gomez-Sanchez L.J. Wagstaff N. Musner G. Otto M. Janz R. Mirsky K.R. Jessen April 01, 2017 / Br J Haematol Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012) N. Baras S. Dahm J. Haberland M. Janz K. Emrich K. Kraywinkel A. Salama March 01, 2017 / Leukemia Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma K.D. Wurster F. Hummel J. Richter M. Giefing S. Hartmann M.L. Hansmann S. Kreher K. Köchert D. Krappmann W. Klapper M. Hummel S.S. Wenzel G. Lenz M. Janz B. Dörken R. Siebert S. Mathas
January 01, 2005 / Blood Immunomodulatory derivative of thalidomide (IMiD CC-4047) induces a shift in lineage commitment by suppressing erythropoiesis and promoting myelopoiesis K.R. Koh M. Janz M.Y. Mapara B. Lemke D. Stirling B. Doerken M. Zenke S. Lentzsch
April 01, 2006 / Cell Death Differ Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma I. Sturm C. Stephan B. Gillissen R. Siebert M. Janz S. Radetzki K. Jung S. Loening B. Doerken P.T. Daniel
February 01, 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
May 15, 2006 / Cell Cycle Reprogramming of B lymphoid cells in human lymphoma pathogenesis M. Janz B. Doerken S. Mathas
August 25, 2005 / Blood Elevated NF-kappaB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large cell, and other peripheral T-cell lymphomas S. Mathas K. Joehrens S. Joos A. Lietz F. Hummel M. Janz F. Jundt I. Anagnostopoulos K. Bommert P. Lichter H. Stein C. Scheidereit B. Doerken
March 15, 2006 / Blood Classical Hodgkin lymphoma is characterized by high constitutive expression of activating transcription factor 3 (ATF3) which promotes viability of Hodgkin/Reed-Sternberg cells M. Janz M. Hummel M. Truss B. Wollert-Wulf S. Mathas K. Joehrens C. Hagemeier K. Bommert H. Stein B. Doerken R.C. Bargou
September 19, 2017 / Nat Commun RNA localization is a key determinant of neurite-enriched proteome A. Zappulo D. van den Bruck C. Ciolli Mattioli V. Franke K. Imami E. McShane M. Moreno-Estelles L. Calviello A. Filipchyk E. Peguero-Sanchez T. Müller A. Woehler C. Birchmeier E. Merino N. Rajewsky U. Ohler E.O. Mazzoni M. Selbach A. Akalin M. Chekulaeva
December 13, 2017 / J Neurosci Graded elevation of c-Jun in Schwann cells in vivo: gene dosage determines effects on development, remyelination, tumorigenesis, and hypomyelination S.V. Fazal J.A. Gomez-Sanchez L.J. Wagstaff N. Musner G. Otto M. Janz R. Mirsky K.R. Jessen
April 01, 2017 / Br J Haematol Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012) N. Baras S. Dahm J. Haberland M. Janz K. Emrich K. Kraywinkel A. Salama
March 01, 2017 / Leukemia Inactivation of the putative ubiquitin-E3 ligase PDLIM2 in classical Hodgkin and anaplastic large cell lymphoma K.D. Wurster F. Hummel J. Richter M. Giefing S. Hartmann M.L. Hansmann S. Kreher K. Köchert D. Krappmann W. Klapper M. Hummel S.S. Wenzel G. Lenz M. Janz B. Dörken R. Siebert S. Mathas